Identification of a human antibody 3.19.3 that inhibits ANG-2 function leading to significant anti-tumor activity in a panel of tumor xenograft models

被引：0
|
作者：
Blakey, David
Emery, Steve
Zhou, Qing
Kendrew, Jane
Cao, Zhu
Brown, Jeff
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
[2] Abgenix Inc, Fremont, CA USA
[3] AstraZeneca, Waltham, MA USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-tumor efficacy of the 3.19.3 ANG-2 antibody in combination with VEGF inhibitors in tumor xenograft models
    Brown, Jeff
    Cao, Zhu
    Reimer, Corinne
    Zhou, Qing
    Kendrew, Jane
    Ryan, Anderson
    Jurgensmeier, Juliane
    Emery, Steve
    Blakey, David
    CANCER RESEARCH, 2009, 69
  • [2] MEDI3617, a human anti-Angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models
    Leow, Ching Ching
    Coffman, Karen
    Inigo, Ivan
    Breen, Shannon
    Czapiga, Meggan
    Soukharev, Serguei
    Gingles, Neill
    Peterson, Norman
    Fazenbaker, Christine
    Woods, Rob
    Jallal, Bahija
    Ricketts, Sally-Ann
    Lavallee, Theresa
    Coats, Steve
    Chang, Yong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (05) : 1321 - 1330
  • [3] Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
    Kloepper, Jonas
    Riedemann, Lars
    Amoozgar, Zohreh
    Seano, Giorgio
    Susek, Katharina
    Yu, Veronica
    Dalvie, Nisha
    Amelung, Robin L.
    Datta, Meenal
    Song, Jonathan W.
    Askoxylakis, Vasileios
    Taylor, Jennie W.
    Lu-Emerson, Christine
    Batista, Ana
    Kirkpatrick, Nathaniel D.
    Jung, Keehoon
    Snuderl, Matija
    Muzikansky, Alona
    Stubenrauch, Kay G.
    Krieter, Oliver
    Wakimoto, Hiroaki
    Xu, Lei
    Munn, Lance L.
    Duda, Dan G.
    Fukumura, Dai
    Batchelor, Tracy T.
    Jain, Rakesh K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (16) : 4476 - 4481
  • [4] Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
    Kloepper, Jonas
    Riedemann, Lars
    Amoozgar, Zohreh
    Seano, Giorgio
    Susek, Katharina H.
    Yu, Veronica
    Dalvie, Nisha
    Amelung, Robin L.
    Datta, Meenal
    Song, Jonathan W.
    Askoxylakis, Vasileios
    Taylor, Jennie W.
    Lu-Emerson, Christine
    Batista, Ana
    Kirkpatrick, Nathaniel D.
    Jung, Keehoon
    Snuderl, Matija
    Muzikansky, Alona
    Stubenrauch, Kay G.
    Krieter, Oliver
    Wakimoto, Hiroaki
    Xu, Lei
    Munn, Lance L.
    Duda, Dan G.
    Fukumura, Dai
    Batchelor, Tracy T.
    Jain, Rakesh K.
    CANCER RESEARCH, 2016, 76
  • [5] Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
    Siders, William M.
    Shields, Jacqueline
    Garron, Carrie
    Hu, Yanping
    Boutin, Paula
    Shankara, Srinivas
    Weber, William
    Roberts, Bruce
    Kaplan, Johanne M.
    LEUKEMIA & LYMPHOMA, 2010, 51 (07) : 1293 - 1304
  • [6] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wei-De Wu
    Pin-Shern Chen
    Hany A. Omar
    El-Shaimaa A. Arafa
    Hung-Wei Pan
    Jingyueh Jeng
    Jui-Hsiang Hung
    Scientific Reports, 8
  • [7] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wu, Wei-De
    Chen, Pin-Shern
    Omar, Hany A.
    Arafa, El-Shaimaa A.
    Pan, Hung-Wei
    Jeng, Jingyueh
    Hung, Jui-Hsiang
    SCIENTIFIC REPORTS, 2018, 8
  • [8] Selection of a huC242-maytansinoid conjugate with the highest anti-tumor activity in multiple human tumor xenograft models
    Xie, Hongsheng
    Garrett, Lisa
    Kovtun, Yelena
    Steeves, Rita
    Lutz, Robert
    Goldmacher, Victor
    Erickson, Hans
    Leece, Barbara
    Whiteman, Kathleen
    Blattler, Walter
    Chari, Ravi
    CANCER RESEARCH, 2006, 66 (08)
  • [9] TRU-015, a novel CD20-directed biologic therapy, demonstrates significant anti-tumor activity in human tumor xenograft models.
    Barone, D
    Nilsson, C
    Ledbetter, J
    Hayden-Ledbetter, M
    Mohler, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 178S - 178S
  • [10] Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models
    Fariba Shiravi
    Mehdi Mohammadi
    Forough Golsaz-Shirazi
    Tannaz Bahadori
    Mohammad Ali Judaki
    Forough Fatemi
    Hengameh Ahmadi Zare
    Farzaneh Notash Haghighat
    Maryam Mobini
    Mahmood Jeddi-Tehrani
    Mohammad Mehdi Amiri
    Fazel Shokri
    Investigational New Drugs, 2021, 39 : 697 - 704
12345